Sometimes stories that seek to go deeper than what the immediate headlines and the most obvious angles offer are richly rewarded by audience attention. And most-read story of this week falls in that category where it pulls back the curtain from a failed cancer trial to reveal the hype that surrounds the novel cancer immunotherapy.
Other popular stories were an analysis of Apple’s recent purchase of a personal health record company and looking at diabetes in a new way.
What no one is telling you about BMS’ Opdivo immunotherapy trial failure
Apple said to acquire PHR vendor Gliimpse; should anyone care?
Watch out, EpiPen: A better auto-injector for severe allergies is in the works
Iodine completes first mental health integration of Apple CareKit-developed app
Image: Getty Images, Meriel Jane Waissman
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
